Cozaar: Clinical Trials

10 trials of Cozaar, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 terminated, 1 suspended. 10 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 110Completed 7, Terminated 2, Suspended 1
Phase 23Completed 1, Suspended 1, Terminated 1

Follow Cozaar: new trials by email Literature Review of Cozaar trials Research Report on Cozaar

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Losartan on Cephalexin
losartan, cephalexin - Possible Interaction Between Losartan and Cephalexin, Healthy
Phase 1CompletedAleksi Tornio132026-03-042026-10-01
Study of Open Label Losartan in COVID-19
Losartan - COVID-19
Phase 1CompletedUniversity of Kansas Medical Center342020-04-042024-08-02
Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer
Hypofractionated Radiation Therapy, Losartan, Losartan Potassium - Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma
Phase 1CompletedUniversity of Utah222019-08-082026-07-06
Pilot Trial: the Safety and Feasibility of Losartan for Pulmonary Vein Stenosis
Losartan - Pulmonary Vein Stenosis, Children
Phase 1 / Phase 2SuspendedThe Hospital for Sick Children402016-05-012019-07-30
Pilot Study of Losartan and N-acetylcysteine as Inhibitors of Muscle Oxidative Stress in Elderly
N-acetylcysteine, Losartan, Placebo losartan - Aging
Phase 1 / Phase 2CompletedThe University of Texas Medical Branch, Galveston62011-07-012018-05-08
Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
Losartan, Captopril, Placebo - Hypertension, Pure Autonomic Failure
Phase 1TerminatedVanderbilt University122011-03-012018-08-24
Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers
Propranolol, Losartan, Eprosartan - Kidney Disease
Phase 1CompletedUniversity of California, San Francisco242010-03-012013-05-30
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Losartan, Zileuton, N-Acetylcysteine - Hermansky-Pudlak Syndrome (HPS), Pulmonary Fibrosis
Phase 1 / Phase 2TerminatedNational Human Genome Research Institute (NHGRI)32007-04-012013-08-02
The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)
losartan potassium, Comparator: isosorbide mononitrate (ISMN), Comparator: losartan + ISMN - Hypertension
Phase 1CompletedOrganon and Co132006-08-012022-02-09
Treatment of Supine Hypertension in Autonomic Failure
Clonidine, Nitroglycerin transdermal, Dipyridamole/ Aspirin (Aggrenox) - Hypertension
Phase 1CompletedVanderbilt University1522001-01-012017-10-13

Conditions studied

Hypertension (3)  ·  Multiple System Atrophy (2)  ·  Pure Autonomic Failure (2)  ·  Albinism (1)  ·  Albinism, Oculocutaneous (1)  ·  COVID-19 (1)  ·  Hermanski-Pudlak Syndrome (1)  ·  Kidney Diseases (1)  ·  Lung Diseases (1)  ·  Metabolic Diseases (1)  ·  Pancreatic Neoplasms (1)  ·  Platelet Storage Pool Deficiency (1)  ·  Pulmonary Fibrosis (1)  ·  Respiratory Insufficiency (1)  ·  Shy-Drager Syndrome (1)

Sponsors

Vanderbilt University (2)  ·  Aleksi Tornio (1)  ·  National Human Genome Research Institute (NHGRI) (1)  ·  Organon and Co (1)  ·  The Hospital for Sick Children (1)  ·  The University of Texas Medical Branch, Galveston (1)  ·  University of California, San Francisco (1)  ·  University of Kansas Medical Center (1)  ·  University of Utah (1)

Countries

United States (7)  ·  Canada (1)  ·  Finland (1)

Top investigators

Italo Biaggioni, MD (2)  ·  Aleksi Tornio, M.D., Ph.D. (1)  ·  Astrid M Horstman, PhD (1)  ·  Christopher A Caldarone, MD (1)  ·  Leslie Z Benet, PhD (1)  ·  Lynda Frassetto, MD (1)  ·  Matthias Salathe (1)  ·  Melinda Sheffield-Moore, PhD (1)  ·  Shane Lloyd (1)  ·  Thomas Markello, M.D. (1)

Results publications

PMID 10851208, PMID 11927799, PMID 12119802, PMID 12923400, PMID 15738343, PMID 16391172, PMID 16533484, PMID 18426998, PMID 19047577, PMID 19738158, PMID 21130977, PMID 22801444, PMID 23266540, PMID 32658300, PMID 9369256, PMID 9890307

NIH funding

2025 (1)